The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all detectable traces of a brain cancer.

AiBST, founded in 2002, is developing research competence in drug discovery on the continent. To help address efficacy differences, AiBST has developed an inclusive genetic test which considers varied ...

Clinical Assessment Is Being Performed on a Pediatric Patient at Children’s Health Ireland in Dublin First Evaluation of ...

SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, was ...

The catalogue of genetic factors that have been implicated in kidney disease continues to grow. In this guide to gene–disease relationships, the authors discuss the crucial process whereby ...

Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...

Production tips from Crystal Bio, TriLink Biotechnologies, Ginkgo Bioworks, Quantoom Biosciences, and Parexel.

Human-specific diseases cannot be accurately modeled by animals, leading to limited medical options or advancements This new study leverages the capabilities of artificial intelligence (AI) and ...

In 2014, the U.S. Food and Drug Administration approved the first multi-target stool-based colorectal screening test, in ...

As genetic testing becomes more available, patients are gaining unprecedented access to information about the likelihood of diseases and medical conditions. There is increased demand for professionals ...